The company's databases encompass all available data from published medical science research across various disease and condition areas. This vast dataset can be analyzed in seconds, allowing users to filter and query the data to answer specific questions. MedAware Systems excels in meticulously extracting, organizing, and standardizing millions of data points, making the entirety of medical research literature exceptionally accessible at a detailed level.
Additionally, the company offers AI-enabled surveillance of both published literature and adverse events reported in regulatory databases. Since its founding in 2013, MedAware Systems has focused on leveraging Big Data, Health Care, Information Technology, and Pharmaceutical industries to revolutionize the accessibility and comprehension of medical research data.
The company's most recent investment of $150.00K in a Venture Round came on 30 January 2018, denoting a continued interest in its innovative approach. As MedAware Systems continues to disrupt the healthcare and pharmaceutical landscape, its expansion into payers' market is a promising sign of its growing influence. With its headquarters in Broomfield, Colorado, the company stands at the intersection of technology and healthcare, poised to make a lasting impact.
